NBME bone q

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

MudPhud20XX

Full Member
10+ Year Member
Joined
Nov 26, 2013
Messages
1,351
Reaction score
193
A 65 yr old woman comes to the physician for a follow-up examination after a DEXA scan showed a decrease in bone density. Physical examination shows no abnormalities. Which one of the following sets of findings in bone is most likely in this patient?

upload_2014-9-12_5-20-57.png


So she is most likely in menopause so should have low osteoblast and high osteoclast right? So I am debating between D and E, right? Can anyone explain how to approach for the third column? Many thanks in advance.

Members don't see this ad.
 
Yup that's right. Osteoblasts= low, osteoclasts= high (no apoptosis due to lack to estrogen) and RANKL= high. The reason is that osteoclasts need something to tell it to start working on reabosrbing bone. And that signal is RANKL.

RANK-L on Osteoblast increase- which then in turn bind RANK on osteoclasts.


As a side note : There seems to be an error in FA2014 page 314
the correct sequence is that PTH increases expression of RANK-L on osteoblasts, which then binds RANK on Osteoclasts. The receptor for RANK are on the osteroclasts. Osteoclasts then eat bone
 
Last edited:
  • Like
Reactions: 1 user
RANKL is the signal peptide ligand secreted by the osteoblasts that promote osteoclast differentiation. It's levels will correlate positively with osteoclast activity.
 
  • Like
Reactions: 1 user
Top